{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:14:02Z","timestamp":1792516442049,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011747","name":"Novo Nordisk Foundation Center for Basic Metabolic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF10CC1016515"],"award-info":[{"award-number":["NNF10CC1016515"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF140C0013655"],"award-info":[{"award-number":["NNF140C0013655"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0024830"],"award-info":[{"award-number":["NNF17OC0024830"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.molmet.2023.101757","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T20:57:09Z","timestamp":1687294629000},"page":"101757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2"],"prefix":"10.1016","volume":"74","author":[{"given":"Jacob Emil","family":"Petersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Hauge","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Dmytriyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Nellemose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulika","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja Storm","family":"Engelstoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-218X","authenticated-orcid":false,"given":"Wesley B.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7395-2967","authenticated-orcid":false,"given":"Jonathan A.","family":"Javitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thue W.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6908-106X","authenticated-orcid":false,"given":"Mette","family":"Trauelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6928","key":"10.1016\/j.molmet.2023.101757_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.molmet.2023.101757_bib2","doi-asserted-by":"crossref","first-page":"11303","DOI":"10.1074\/jbc.M211495200","article-title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids","volume":"278","author":"Briscoe","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"9","key":"10.1016\/j.molmet.2023.101757_bib3","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2337\/db08-0307","article-title":"Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion","volume":"57","author":"Edfalk","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.molmet.2023.101757_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cmet.2008.11.002","article-title":"Glucose sensing in L cells: a primary cell study","volume":"8","author":"Reimann","year":"2008","journal-title":"Cell Metabol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101757_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2018.01.006","article-title":"The HETE is on FFAR1 and pancreatic islet cells","volume":"27","author":"Trauelsen","year":"2018","journal-title":"Cell Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101757_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-017-02539-4","article-title":"20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1","volume":"9","author":"Tunaru","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.molmet.2023.101757_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bph.12297","article-title":"TAK-875, a GPR40\/FFAR1 agonist, in combination with metformin prevents progression of diabetes and \u03b2-cell dysfunction in Zucker diabetic fatty rats","volume":"170","author":"Ito","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"7","key":"10.1016\/j.molmet.2023.101757_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/dom.12442","article-title":"GPR40 agonists for the treatment of type 2 diabetes: life after \u201cTAKing\u201d a hit","volume":"17","author":"Mancini","year":"2015","journal-title":"Diabetes Obes Metabol"},{"issue":"9824","key":"10.1016\/j.molmet.2023.101757_bib9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(11)61879-5","article-title":"TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"379","author":"Burant","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.molmet.2023.101757_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1379","article-title":"Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis","volume":"41","author":"Desai","year":"2018","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.molmet.2023.101757_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s40264-018-0642-6","article-title":"Liver safety of fasiglifam (TAK-875) in patients with type 2 diabetes: review of the global clinical trial experience","volume":"41","author":"Marcinak","year":"2018","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.molmet.2023.101757_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/dmd.114.061580","article-title":"Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics","volume":"43","author":"Wang","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.molmet.2023.101757_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/toxsci\/kfx040","article-title":"Fasiglifam (TAK-875): mechanistic investigation and retrospective identification of hazards for drug induced liver injury","volume":"163","author":"Otieno","year":"2018","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.molmet.2023.101757_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/ml300427u","article-title":"Discovery and optimization of potent GPR40 full agonists containing tricyclic spirocycles","volume":"4","author":"Wang","year":"2013","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.molmet.2023.101757_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2014.10.002","article-title":"GPR40 (FFAR1) - combined Gs and Gq signaling in\u00a0vitro is associated with robust incretin secretagogue action ex\u00a0vivo and in\u00a0vivo","volume":"4","author":"Hauge","year":"2015","journal-title":"Mol Metabol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101757_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0006-291X(02)03064-4","article-title":"A\u00a0human cell surface receptor activated by free fatty acids and thiazolidinedione drugs","volume":"301","author":"Kotarsky","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.molmet.2023.101757_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mce.2016.11.024","article-title":"Gq and Gs signaling acting in synergy to control GLP-1 secretion","volume":"449","author":"Hauge","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.molmet.2023.101757_bib18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors","volume":"3","author":"Pierce","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.molmet.2023.101757_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/mol.117.111369","article-title":"GPR40-Mediated G\u03b112 activation by allosteric full agonists highly efficacious at potentiating glucose-stimulated insulin secretion in human islets","volume":"93","author":"Rives","year":"2018","journal-title":"Mol Pharmacol"},{"issue":"14","key":"10.1016\/j.molmet.2023.101757_bib20","doi-asserted-by":"crossref","first-page":"10576","DOI":"10.1074\/jbc.M609695200","article-title":"Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate\/G13 pathway","volume":"282","author":"Jiang","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.molmet.2023.101757_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10156","article-title":"The experimental power of FR900359 to study Gq-regulated biological processes","volume":"6","author":"Schrage","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.molmet.2023.101757_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/mol.116.106419","article-title":"Purinergic receptor transactivation by the \u03b22-adrenergic receptor increases intracellular Ca2+ in nonexcitable cells","volume":"91","author":"Stallaert","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101757_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/mol.113.090563","article-title":"Discovery and characterization of a G protein-biased agonist that inhibits \u03b2-arrestin recruitment to the D2 dopamine receptor","volume":"86","author":"Free","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101757_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-008-1202-x","article-title":"Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells","volume":"52","author":"Parker","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.molmet.2023.101757_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.molmet.2013.08.006","article-title":"Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells","volume":"2","author":"Engelstoft","year":"2013","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2023.101757_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-2914-6_8","article-title":"Monitoring G protein activation in cells with BRET","volume":"1335","author":"Masuho","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101757_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1042\/BJ20130359","article-title":"AKAP79, PKC, PKA and PDE4 participate in a Gq-linked muscarinic receptor and adenylate cyclase 2 cAMP signalling complex","volume":"455","author":"Shen","year":"2013","journal-title":"Biochem J"},{"issue":"19","key":"10.1016\/j.molmet.2023.101757_bib28","doi-asserted-by":"crossref","first-page":"13900","DOI":"10.1016\/S0021-9258(19)85187-6","article-title":"Type II adenylylcyclase integrates coincident signals from Gs, Gi, and Gq","volume":"268","author":"Lustig","year":"1993","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.molmet.2023.101757_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tips.2018.02.005","article-title":"Genome editing provides new insights into receptor-controlled signalling pathways","volume":"39","author":"Milligan","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.molmet.2023.101757_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.molmet.2018.03.004","article-title":"Enterochromaffin 5-HT cells - a major target for GLP-1 and gut microbial metabolites","volume":"11","author":"Lund","year":"2018","journal-title":"Mol Metabol"},{"issue":"16","key":"10.1016\/j.molmet.2023.101757_bib31","article-title":"In-vitro GLP-1 release assay using STC-1 cells","volume":"10","author":"Qi","year":"2020","journal-title":"Bio Protoc"},{"issue":"5","key":"10.1016\/j.molmet.2023.101757_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/diabetes.52.5.1147","article-title":"A\u00a0novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line","volume":"52","author":"Gribble","year":"2003","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.molmet.2023.101757_bib33","first-page":"337","article-title":"Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase","volume":"8","author":"Green","year":"1982","journal-title":"J\u00a0Cyclic Nucl Res"},{"issue":"1","key":"10.1016\/j.molmet.2023.101757_bib34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/s41467-017-01240-w","article-title":"Structural basis for GPR40 allosteric agonism and incretin stimulation","volume":"9","author":"Ho","year":"2018","journal-title":"Nat Commun"},{"issue":"7516","key":"10.1016\/j.molmet.2023.101757_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature13494","article-title":"High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875","volume":"513","author":"Srivastava","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.molmet.2023.101757_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nsmb.3417","article-title":"Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40","volume":"24","author":"Lu","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.molmet.2023.101757_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ceb.2019.12.005","article-title":"Structural basis for GPCR signaling by small polar versus large lipid metabolites-discovery of non-metabolite ligands","volume":"63","author":"L\u00fcckmann","year":"2020","journal-title":"Curr Opin Cell Biol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823000911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:35:00Z","timestamp":1761957300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823000911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":37,"alternative-id":["S2212877823000911"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101757","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101757","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101757"}}